PUBLISHER: Daedal Research | PRODUCT CODE: 1556874
PUBLISHER: Daedal Research | PRODUCT CODE: 1556874
Global Stem Cell Therapy Market: Analysis By Type, By Stem Cell Source, By Application, By End User, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029
Stem cell therapy is a form of treatment that involves the use of stem cells to repair, replace, or regenerate damaged or diseased tissues in the body. Stem cells are unique because they have the ability to develop into different types of cells, such as muscle cells, nerve cells, or blood cells. This versatility makes them a valuable tool in regenerative medicine. While there are a growing number of potential therapies being tested in clinical trials there are only a few stem cell therapies that have so far been approved. The global stem cell therapy market value in 2023 stood at US$9.65 billion, and is likely to reach US$23.07 billion by 2029.
The stem cell therapy market has experienced significant growth over the years primarily due to rising prevalence and incidence of chronic diseases. Conditions such as musculoskeletal disorders, cardiovascular diseases, and neurological disorders have become increasingly prevalent, leading to a growing demand for innovative and effective treatments. Stem cell therapies have emerged as a promising solution, offering potential regenerative and therapeutic benefits for these conditions. Further, advancement in regulatory frameworks and increased public-private investments in developing innovative stem cell solutions have also played a crucial role. Additionally, technological advancements in cell therapy manufacturing and the emergence of new technologies, such as induced pluripotent stem cells (iPSCs), have further propelled market growth. Other significant trends including increasing demand for regenerative medicine, positive shift towards personalized medicine, the emergence of iPSCs as an Alternative to ESCs, etc. are expected to drive market growth further. The global stem cell therapy market value is projected to grow at a CAGR of 15.97%, during the forecast period of 2024-2029.
Market Segmentation Analysis:
By Type: According to the report, the global stem cell therapy market is bifurcated into two segments based on the type: Allogeneic and Autologous. Allogeneic segment acquired majority of share in the market in 2023 as allogeneic therapies involve the use of donor cells, which can be more readily available and scalable compared to autologous therapies, making them more attractive for both manufacturers and patients. On the other hand, autologous segment is the fastest growing segment due to due to its personalized approach, where stem cells are harvested from and returned to the same patient, minimizing the risk of immune rejection and enhancing treatment efficacy.
By Stem Cell Source: According to the report, the global stem cell therapy market is bifurcated into four sources of stem cells: adult stem cells, embryonic stem cells, induced pluripotent stem cells, and others. Adult stem cells segment acquired majority of share in the market in 2023 due to their well-established applications, safety profile, and regulatory acceptance. Adult stem cells, such as those derived from bone marrow or adipose tissue, are already widely used in clinical practice for treating conditions like blood disorders and orthopedic injuries. Furthermore, adult stem cells have a lower risk of immune rejection when used in autologous therapies and are supported by a robust body of clinical research, making them a preferred choice for both providers and patients. While, induced pluripotent stem cells segment is expected to grow at the fastest CAGR during forecasted period due to their versatility and potential for personalized medicine. iPSCs can be generated from adult cells and reprogrammed to become any cell type, offering an advantage in developing customized treatments for a wide range of diseases. This flexibility, combined with their ability to bypass the ethical concerns associated with embryonic stem cells, positions iPSCs as a powerful tool in regenerative medicine and research.
By Application: According to the report, the global stem cell therapy market is bifurcated into six applications: musculoskeletal disorders, cardiovascular diseases, oncology, neurological disorders, dermatology and others. Musculoskeletal disorders segment acquired majority of share in the market in 2023, due to the high prevalence of conditions such as osteoarthritis, degenerative disc disease, and sports injuries, which are increasingly being addressed with stem cell-based treatments. Stem cell therapies offer promising solutions for repairing and regenerating damaged tissues, such as cartilage and bone, which are critical in treating musculoskeletal issues. On the other hand, oncology segment is expected to grow at the fastest CAGR during forecasted period due to the increasing application of stem cell therapies in treating various types of cancer and improving patient outcomes. Additionally, ongoing research is exploring the use of stem cells for developing targeted therapies, enhancing the effectiveness of conventional treatments, and addressing cancer metastasis. As advancements continue and new therapies receive approval, the oncology segment is poised for rapid expansion, driven by a growing need for innovative cancer treatments and improved survival rates.
By End-user: The report further bifurcates the market into three end-users: hospitals and specialty clinics, academic and research institutes and others. Hospitals and specialty clinics segment acquired majority of share in the market in 2023 due to their central role in delivering advanced medical treatments and managing complex patient cases. Additionally, hospitals and specialty clinics are increasingly integrating stem cell treatments into their service offerings, driven by rising patient demand for innovative therapies and the growing availability of approved stem cell treatments. This focus on cutting-edge care and personalized medicine contributes to the segment's substantial market share and rapid growth.
By Region: The report provides insight into the stem cell therapy market based on the geographical operations, namely, North America, Europe, Asia Pacific, and rest of the world. North America stem cell therapy market enjoyed the highest market share in 2023 due to its advanced healthcare infrastructure, significant investment in research and development, and a well-established regulatory framework that supports innovation and commercialization. The region benefits from a high number of leading biotech companies, extensive clinical trial activities, and substantial funding from both public and private sectors. Additionally, the presence of prominent research institutions and a strong focus on developing and adopting cutting-edge medical technologies contribute to North America's dominant position in the global stem cell therapy market.
While, Asia Pacific region has been experiencing the fastest growth in the global stem cell therapy market due to a combination of rapidly advancing healthcare infrastructure, increasing investment in biotechnology, and a growing emphasis on research and development. The region's large and diverse patient population, coupled with rising prevalence of chronic diseases, has heightened demand for innovative treatments. Additionally, favorable government policies, such as regulatory reforms and funding initiatives, along with cost-effective manufacturing capabilities, have attracted both domestic and international players to invest in stem cell research and therapy, further driving the market's expansion in this region.
Global Stem cell therapy Market Dynamics:
Growth Drivers: The rising incidence of chronic diseases such as diabetes, heart disease, and neurodegenerative disorders is a significant growth driver of the global stem cell therapy market because these conditions often lead to substantial morbidity and require advanced treatment options. Stem cell therapies offer promising solutions by potentially regenerating damaged tissues, restoring lost functions, and providing innovative alternatives to conventional treatments. As the prevalence of these chronic diseases continues to increase globally, there is a growing demand for effective and long-lasting therapeutic options, thereby driving investment and development in stem cell research and applications. Other factors driving the growth of global stem cell therapy market include rise in cancer incidence, rapidly expanding biotechnology sector, favorable government initiatives, growing demand for stem cells banking, etc.
Challenges: Ethical concerns present a significant challenge for the global stem cell therapy market, particularly regarding the use of embryonic stem cells, which involve the destruction of embryos. These concerns stem from debates about the moral status of embryos and the implications of their use in research and treatment. While induced pluripotent stem cells (iPSCs) and adult stem cells offer alternatives that mitigate some of these ethical issues, the controversy surrounding embryonic stem cells can still influence public perception, regulatory policies, and funding availability. Addressing these ethical concerns is crucial for ensuring broad acceptance and progress in stem cell therapies. Other challenge might include high cost of treatment.
Trends: The increasing demand for regenerative medicine is a significant trend in the global stem cell therapy market, driven by the growing need for innovative treatments to repair or replace damaged tissues and organs. As traditional medical approaches often fall short in addressing chronic, degenerative, or age-related conditions, regenerative medicine, including stem cell therapies, offers new possibilities for restoring health and improving quality of life. This rising demand is fueled by advancements in technology, expanding clinical applications, and heightened patient awareness, all of which contribute to accelerated research, development, and commercialization of stem cell-based therapies. The market is also projected to grow at a fast pace during the forecast period, due to various other latest trends such as increasing demand for regenerative medicine, positive shift towards personalized medicine, the emergence of IPSCs as an alternative to ESCs, ongoing technological advancements, etc.
Competitive Landscape and Recent Developments:
The global stem cell therapy market is partially fragmented catering to domestic and international demand. Players operating in the global stem cell therapy market focus on providing high-quality products to fulfill customer demand. They also focus on strategies such as investments in research and development activities, new product launches, and expanding production capacities. Key players of global stem cell therapy market are:
Vertex Pharmaceuticals Incorporated
Bayer AG (BlueRock Therapeutics LP)
BioRestorative Therapies, Inc.
Athersys, Inc.
JCR Pharmaceuticals Co., Ltd.
ReNeuron Group plc
MEDIPOST Co., Ltd.
Fondazione Enea Tech e Biomedical (HOLOSTEM S.r.l.)
Aspen Neuroscience
Garuda Therapeutics
Stempeutics Research Pvt Ltd.
Table of Contents
- 2.1 Stem Cell Therapy: An Overview
- 2.1.1 Definition of Stem Cell Therapy
- 2.1.2 Benefits of Stem Cell Therapy
- 2.1.3 Applications of Stem Cells
- 2.2 Stem Cell Therapy Segmentation: An Overview
- 2.2.1 Stem Cell Therapy Segmentation
- 3.1 Global Stem Cell Therapy Market: An Analysis
- 3.1.1 Global Stem Cell Therapy Market: An Overview
- 3.1.2 Global Stem Cell Therapy Market by Value
- 3.1.3 Global Stem Cell Therapy Market by Type (Allogeneic and Autologous)
- 3.1.4 Global Stem Cell Therapy Market by Stem Cell Source (Adult Stem Cells, Embryonic Stem Cells, Induced Pluripotent Stem Cells, and Others)
- 3.1.5 Global Stem Cell Therapy Market by Application (Musculoskeletal Disorders, Cardiovascular Diseases, Oncology, Neurological Disorders, Dermatology and Others)
- 3.1.6 Global Stem Cell Therapy Market by End User (Hospitals & Specialty Clinics, Academic & Research Institutes and Others)
- 3.1.7 Global Stem Cell Therapy Market by Region (North America, Europe, Asia Pacific and Rest of the world)
- 3.2 Global Stem Cell Therapy Market: Type Analysis
- 3.2.1 Global Stem Cell Therapy Market: Type Overview
- 3.2.2 Global Allogeneic Stem Cell Therapy Market by Value
- 3.2.3 Global Autologous Stem Cell Therapy Market by Value
- 3.3 Global Stem Cell Therapy Market: Stem Cell Source Analysis
- 3.3.1 Global Stem Cell Therapy Market by Stem Cell Source: An Overview
- 3.3.2 Global Adult Stem Cell Therapy Market by Value
- 3.3.3 Global Embryonic Stem Cell Therapy Market by Value
- 3.3.4 Global Induced Pluripotent Stem Cell Therapy Market by Value
- 3.3.5 Global Others Stem Cell Therapy Market by Value
- 3.4 Global Stem Cell Therapy Market: Application Analysis
- 3.4.1 Global Stem Cell Therapy Market by Application: An Overview
- 3.4.2 Global Musculoskeletal Disorders Stem Cell Therapy Market by Value
- 3.4.3 Global Cardiovascular Diseases Stem Cell Therapy Market by Value
- 3.4.4 Global Oncology Stem Cell Therapy Market by Value
- 3.4.5 Global Neurological Disorders Stem Cell Therapy Market by Value
- 3.4.6 Global Dermatology Stem Cell Therapy Market by Value
- 3.4.7 Global Others Stem Cell Therapy Market by Value
- 3.5 Global Stem Cell Therapy Market: End User Analysis
- 3.5.1 Global Stem Cell Therapy Market: End User Overview
- 3.5.2 Global Hospitals & Specialty Clinics Stem Cell Therapy Market by Value
- 3.5.3 Global Academic and Research Institutes Stem Cell Therapy Market by Value
- 3.5.4 Global Others Stem Cell Therapy Market by Value
- 4.1 North America Stem Cell Therapy Market: An Analysis
- 4.1.1 North America Stem Cell Therapy Market: An Overview
- 4.1.2 North America Stem Cell Therapy Market by Value
- 4.1.3 North America Stem Cell Therapy Market by Region (The US, Canada and Mexico)
- 4.1.4 The US Stem Cell Therapy Market by Value
- 4.1.5 Canada Stem Cell Therapy Market by Value
- 4.1.6 Mexico Stem Cell Therapy Market by Value
- 4.2 Europe Stem Cell Therapy Market: An Analysis
- 4.2.1 Europe Stem Cell Therapy Market: An Overview
- 4.2.2 Europe Stem Cell Therapy Market by Value
- 4.2.3 Europe Stem Cell Therapy Market by Region (Germany, UK, France, Italy and Rest of Europe)
- 4.2.4 Germany Stem Cell Therapy Market by Value
- 4.2.5 UK Stem Cell Therapy Market by Value
- 4.2.6 France Stem Cell Therapy Market by Value
- 4.2.7 Italy Stem Cell Therapy Market by Value
- 4.2.8 Rest of Europe Stem Cell Therapy Market by Value
- 4.3 Asia Pacific Stem Cell Therapy Market: An Analysis
- 4.3.1 Asia Pacific Stem Cell Therapy Market: An Overview
- 4.3.2 Asia Pacific Stem Cell Therapy Market by Value
- 4.3.3 Asia Pacific Stem Cell Therapy Market by Region (China, Japan, India, South Korea and Rest of Asia Pacific)
- 4.3.4 China Stem Cell Therapy Market by Value
- 4.3.5 Japan Stem Cell Therapy Market by Value
- 4.3.6 India Stem Cell Therapy Market by Value
- 4.3.7 South Korea Stem Cell Therapy Market by Value
- 4.3.8 Rest of Asia Pacific Stem Cell Therapy Market by Value
- 4.4 Rest of the World Stem Cell Therapy Market: An Analysis
- 4.4.1 Rest of the World Stem Cell Therapy Market: An Overview
- 4.4.2 Rest of the World Stem Cell Therapy Market by Value
- 5.1 Impact of COVID-19 on Global Stem Cell Therapy Market
- 5.2 Post COVID-19 Impact on Global Stem Cell Therapy Market
- 6.1 Growth Drivers
- 6.1.1 Rise in Cancer Incidence
- 6.1.2 Rapidly Expanding Biotechnology Sector
- 6.1.3 Favorable Government Initiatives
- 6.1.4 Increasing Prevalence of Chronic Diseases
- 6.1.5 Growing Demand for Stem Cells Banking
- 6.2 Challenges
- 6.2.1 Ethical Concerns
- 6.2.2 High Cost of Treatment
- 6.3 Market Trends
- 6.3.1 Increasing Demand for Regenerative Medicine
- 6.3.2 Positive Shift towards Personalized Medicine
- 6.3.3 Emergence of iPSCs as an Alternative to ESCs
- 6.3.4 Ongoing Technological Advancements
- 7.1 Global Stem Cell Therapy Market: Recent Developments
- 7.2 Global Stem Cell Therapy Market Players: Current Landscape
- 8.1 Vertex Pharmaceuticals Incorporated
- 8.1.1 Business Overview
- 8.1.2 Revenues by Geographic Location
- 8.1.3 Business Strategy
- 8.2 JCR Pharmaceuticals Co., Ltd.
- 8.2.1 Business Overview
- 8.2.2 Sales by Product
- 8.2.3 Business Strategy
- 8.3 Bayer AG (BlueRock Therapeutics LP)
- 8.3.1 Business Overview
- 8.3.2 Business Strategy
- 8.4 BioRestorative Therapies, Inc.
- 8.4.1 Business Overview
- 8.4.2 Business Strategy
- 8.5 Athersys, Inc.
- 8.5.1 Business Overview
- 8.5.2 Business Strategy
- 8.6 ReNeuron Group plc
- 8.6.1 Business Overview
- 8.6.2 Business Strategy
- 8.7 MEDIPOST Co., Ltd.
- 8.7.1 Business Overview
- 8.7.2 Business Strategy
- 8.8 Fondazione Enea Tech e Biomedical (HOLOSTEM S.r.l.)
- 8.8.1 Business Overview
- 8.8.2 Business Strategy
- 8.9 Aspen Neuroscience
- 8.9.1 Business Overview
- 8.9.2 Business Strategy
- 8.10 Garuda Therapeutics
- 8.10.1 Business Overview
- 8.10.2 Business Strategy
- 8.11 Stempeutics Research Pvt Ltd.
- 8.11.1 Business Overview
1. Executive Summary
2. Introduction
3. Global Market Analysis
4. Regional Market Analysis
5. Impact of COVID-19
6. Market Dynamics
7. Competitive Landscape
8. Company Profiles
List of Tables
- Table 1: Global Stem Cell Therapy Market Players: Current Landscape
List of Figures
- Figure 1: Benefits of Stem Cell Therapy
- Figure 2: Stem Cell Therapy Segmentation
- Figure 3: Global Stem Cell Therapy Market by Value; 2020-2023 (US$ Billion)
- Figure 4: Global Stem Cell Therapy Market by Value; 2024-2029 (US$ Billion)
- Figure 5: Global Stem Cell Therapy Market by Type; 2023 (Percentage, %)
- Figure 6: Global Stem Cell Therapy Market by Stem Cell Source; 2023 (Percentage, %)
- Figure 7: Global Stem Cell Therapy Market by Application; 2023 (Percentage, %)
- Figure 8: Global Stem Cell Therapy Market by End User; 2023 (Percentage, %)
- Figure 9: Global Stem Cell Therapy Market by Region; 2023 (Percentage, %)
- Figure 10: Global Allogeneic Stem Cell Therapy Market by Value; 2020-2023 (US$ Billion)
- Figure 11: Global Allogeneic Stem Cell Therapy Market by Value; 2024-2029 (US$ Billion)
- Figure 12: Global Autologous Stem Cell Therapy Market by Value; 2020-2023 (US$ Billion)
- Figure 13: Global Autologous Stem Cell Therapy Market by Value; 2024-2029 (US$ Billion)
- Figure 14: Global Adult Stem Cell Therapy Market by Value; 2020-2023 (US$ Billion)
- Figure 15: Global Adult Stem Cell Therapy Market by Value; 2024-2029 (US$ Billion)
- Figure 16: Global Embryonic Stem Cell Therapy Market by Value; 2020-2023 (US$ Billion)
- Figure 17: Global Embryonic Stem Cell Therapy Market by Value; 2024-2029 (US$ Billion)
- Figure 18: Global Induced Pluripotent Stem Cell Therapy Market by Value; 2020-2023 (US$ Billion)
- Figure 19: Global Induced Pluripotent Stem Cell Therapy Market by Value; 2024-2029 (US$ Billion)
- Figure 20: Global Others Stem Cell Therapy Market by Value; 2020-2023 (US$ Billion)
- Figure 21: Global Others Stem Cell Therapy Market by Value; 2024-2029 (US$ Billion)
- Figure 22: Global Musculoskeletal Disorders Stem Cell Therapy Market by Value; 2020-2023 (US$ Billion)
- Figure 23: Global Musculoskeletal Disorders Stem Cell Therapy Market by Value; 2024-2029 (US$ Billion)
- Figure 24: Global Cardiovascular Diseases Stem Cell Therapy Market by Value; 2020-2023 (US$ Billion)
- Figure 25: Global Cardiovascular Diseases Stem Cell Therapy Market by Value; 2024-2029 (US$ Billion)
- Figure 26: Global Oncology Stem Cell Therapy Market by Value; 2020-2023 (US$ Billion)
- Figure 27: Global Oncology Stem Cell Therapy Market by Value; 2024-2029 (US$ Billion)
- Figure 28: Global Neurological Disorders Stem Cell Therapy Market by Value; 2020-2023 (US$ Million)
- Figure 29: Global Neurological Disorders Stem Cell Therapy Market by Value; 2024-2029 (US$ Billion)
- Figure 30: Global Dermatology Stem Cell Therapy Market by Value; 2020-2023 (US$ Million)
- Figure 31: Global Dermatology Stem Cell Therapy Market by Value; 2024-2029 (US$ Billion)
- Figure 32: Global Others Stem Cell Therapy Market by Value; 2020-2023 (US$ Billion)
- Figure 33: Global Others Stem Cell Therapy Market by Value; 2024-2029 (US$ Billion)
- Figure 34: Global Hospitals & Specialty Clinics Stem Cell Therapy Market by Value; 2020-2023 (US$ Billion)
- Figure 35: Global Hospitals & Specialty Clinics Stem Cell Therapy Market by Value; 2024-2029 (US$ Billion)
- Figure 36: Global Academic and Research Institutes Stem Cell Therapy Market by Value; 2020-2023 (US$ Billion)
- Figure 37: Global Academic and Research Institutes Stem Cell Therapy Market by Value; 2024-2029 (US$ Billion)
- Figure 38: Global Others Stem Cell Therapy Market by Value; 2020-2023 (US$ Billion)
- Figure 39: Global Others Stem Cell Therapy Market by Value; 2024-2029 (US$ Billion)
- Figure 40: North America Stem Cell Therapy Market by Value; 2020-2023 (US$ Billion)
- Figure 41: North America Stem Cell Therapy Market by Value; 2024-2029 (US$ Billion)
- Figure 42: North America Stem Cell Therapy Market by Region; 2023 (Percentage, %)
- Figure 43: The US Stem Cell Therapy Market by Value; 2020-2023 (US$ Billion)
- Figure 44: The US Stem Cell Therapy Market by Value; 2024-2029 (US$ Billion)
- Figure 45: Canada Stem Cell Therapy Market by Value; 2020-2023 (US$ Million)
- Figure 46: Canada Stem Cell Therapy Market by Value; 2024-2029 (US$ Million)
- Figure 47: Mexico Stem Cell Therapy Market by Value; 2020-2023 (US$ Million)
- Figure 48: Mexico Stem Cell Therapy Market by Value; 2024-2029 (US$ Million)
- Figure 49: Europe Stem Cell Therapy Market by Value; 2020-2023 (US$ Billion)
- Figure 50: Europe Stem Cell Therapy Market by Value; 2024-2029 (US$ Billion)
- Figure 51: Europe Stem Cell Therapy Market by Region; 2023 (Percentage, %)
- Figure 52: Germany Stem Cell Therapy Market by Value; 2020-2023 (US$ Million)
- Figure 53: Germany Stem Cell Therapy Market by Value; 2024-2029 (US$ Million)
- Figure 54: UK Stem Cell Therapy Market by Value; 2020-2023 (US$ Million)
- Figure 55: UK Stem Cell Therapy Market by Value; 2024-2029 (US$ Million)
- Figure 56: France Stem Cell Therapy Market by Value; 2020-2023 (US$ Million)
- Figure 57: France Stem Cell Therapy Market by Value; 2024-2029 (US$ Million)
- Figure 58: Italy Stem Cell Therapy Market by Value; 2020-2023 (US$ Million)
- Figure 59: Italy Stem Cell Therapy Market by Value; 2024-2029 (US$ Million)
- Figure 60: Rest of Europe Stem Cell Therapy Market by Value; 2020-2023 (US$ Million)
- Figure 61: Rest of Europe Stem Cell Therapy Market by Value; 2024-2029 (US$ Million)
- Figure 62: Asia Pacific Stem Cell Therapy Market by Value; 2020-2023 (US$ Billion)
- Figure 63: Asia Pacific Stem Cell Therapy Market by Value; 2024-2029 (US$ Billion)
- Figure 64: Asia Pacific Stem Cell Therapy Market by Region; 2023 (Percentage, %)
- Figure 65: China Stem Cell Therapy Market by Value; 2020-2023 (US$ Million)
- Figure 66: China Stem Cell Therapy Market by Value; 2024-2029 (US$ Million)
- Figure 67: Japan Stem Cell Therapy Market by Value; 2020-2023 (US$ Million)
- Figure 68: Japan Stem Cell Therapy Market by Value; 2024-2029 (US$ Million)
- Figure 69: India Stem Cell Therapy Market by Value; 2020-2023 (US$ Million)
- Figure 70: India Stem Cell Therapy Market by Value; 2024-2029 (US$ Million)
- Figure 71: South Korea Stem Cell Therapy Market by Value; 2020-2023 (US$ Billion)
- Figure 72: South Korea Stem Cell Therapy Market by Value; 2024-2029 (US$ Million)
- Figure 73: Rest of Asia Pacific Stem Cell Therapy Market by Value; 2020-2023 (US$ Million)
- Figure 74: Rest of Asia Pacific Stem Cell Therapy Market by Value; 2024-2029 (US$ Million)
- Figure 75: Rest of the World Stem Cell Therapy Market by Value; 2020-2023 (US$ Million)
- Figure 76: Rest of the World Stem Cell Therapy Market by Value; 2024-2029 (US$ Billion)
- Figure 77: Global Estimated Number of New Cases in Males and Females; 2022-2040 (Million)
- Figure 78: Vertex Pharmaceuticals Incorporated Revenue by Geographic Location; 2023 (Percentage, %)
- Figure 79: JCR Pharmaceuticals Co., Ltd. Sales by Product; 2022 (Percentage, %)
